APA (7th ed.) Citation

Kashiwagi, M., Nakao, K., Yamanaka, S., Yamauchi, I., Yamashita, T., Fujii, T., . . . Bessho, K. (2022). Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo. PLoS ONE, 17(11), 1. https://doi.org/10.1371/journal.pone.0277140

Chicago Style (17th ed.) Citation

Kashiwagi, Marina, et al. "Circulatory C-type Natriuretic Peptide Reduces Mucopolysaccharidosis-associated Craniofacial Hypoplasia in Vivo." PLoS ONE 17, no. 11 (2022): 1. https://doi.org/10.1371/journal.pone.0277140.

MLA (9th ed.) Citation

Kashiwagi, Marina, et al. "Circulatory C-type Natriuretic Peptide Reduces Mucopolysaccharidosis-associated Craniofacial Hypoplasia in Vivo." PLoS ONE, vol. 17, no. 11, 2022, p. 1, https://doi.org/10.1371/journal.pone.0277140.